Hologic Inc.

History

Year	Detail
1985	FDA clears the first nucleic acid test
1987	First dual-energy X-ray absorptiometry system for evaluating osteoporosis
1988	First molecular diagnostic test kit for a sexually transmitted infection
1995	FDA approves the Rapid fFN test.
1996	The launch of the ThinPrep Pap test, a liquid-based cytology for cervical cancer screening
2001	FDA approves the NovaSure endometrial ablation treatment for abnormal uterine bleeding (AUB)
2002	FDA approves the Selenia mammography system
2002	FDA approves the first nucleic acid test for screening donated blood before transfusion
2003	Release of the Tigris DTS system
2008	FDA approves the Procleix Ultrio triplex blood screening assay for HIV-1, hepatitis B, and C
2012	FDA clears the Panther system
2016	FDA clears the new Affirm prone biopsy system
2017	FDA approves Aptima HIV-1 Quant assay, Aptima HCV Quant DX assay, and the Aptima HSV 1 & 2 assay
2020	FDA grants Emergency Use Authorization (EUA) for the Panther Fusion SARS-CoV-2 and Aptima SARS-CoV-2 assays
2023	Hologic participates in the 2023 World Cancer Leaders’ Summit.
2024	FDA approval of Aptima Trichomonas vaginalis assay